ProFound Therapeutics, a company pioneering the expanded human proteome to develop medicines, has announced a four-year ...

© Vetter Pharma International GmbH: Vetter marks the start of new clinical site construction with groundbreaking ceremony.

It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.

Veranova has appointed Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides. Villain brings extensive ...

AAPS has announced the opening and closing plenary speakers for the 2025 PharmSci 360, taking place November 9-12, in San ...

Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.

EUROAPI has signed a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, with a simultaneous closing to ...

Circio Holding ASA and NeoRegen Biotech have signed a second Material Transfer Agreement (MTA) to advance their ongoing ...

Keystone Folding Box Co., a provider of paperboard packaging solutions, has partnered with Med-Con Technologies, a provider ...

Piramal Pharma Solutions, a CDMO and part of Piramal Pharma Ltd., announced a $90 million investment plan to expand two of ...

UI Pharmaceuticals (UIP), a strategic asset of the University of Iowa (UI) College of Pharmacy, has partnered with MimiVax to ...

Bristol Myers Squibb (BMS) received U.S. Food and Drug Administration (FDA) approval for label updates for its CAR T cell ...